In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Elixirr International plc with a team including Jonathan King (Picture – Equity Capital Markets), Jon...
Elixirr Transitions from AIM to Main Market Listing with £325 Million Valuation
PharosAI’s Joint Venture To Boost AI-Assisted Cancer Care
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised PharosAI with a team including Justin Starling (Picture – Corporate M&A). PharosAI, a joint venture...
Bloomsbury Genetic Therapies Limited’s £5 Million Seed Financing
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised UCL Technology Fund with a team including Justin Starling (Picture – Corporate M&A). Bloomsbury Genetic...
Econic Technologies’ Licensing Agreement With Changhua Chemical Technology Company Ltd
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Econic Technologies with a team including Rob Hayes (Picture – IP&IT). Econic Technologies agreef for...
Nexeon’s US$80 Million Funding
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Nexeon with a team including Simon Neill (Competition Law), Rob Hayes (Picture – Corporate M&A),...




















